All Stories

  1. Are People Who Inject Drugs Frequent Users of Emergency Department Services? A Cohort Study (2008–2013)

    Article • Substance Use & Misuse, October 2017, Taylor & Francis

    Dr Tim Spelman

  2. Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities

    Article • Epidemiology and Infection, September 2017, Cambridge University Press

    Dr Tim Spelman

  3. Prognostic indicators in pediatric clinically isolated syndrome

    Article • Annals of Neurology, May 2017, Wiley

    Dr Tim Spelman, Dr Roberto Bergamaschi, Dr Emanuele D'amico

  4. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes

    Article • Leukemia & Lymphoma, February 2017, Taylor & Francis

    Dr Tim Spelman

  5. Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

    Article • Multiple Sclerosis Journal, November 2016, SAGE Publications

    Dr Tim Spelman

  6. Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Article • Annals of Clinical and Translational Neurology, February 2015, Wiley

    Dr Tim Spelman, Dr Tomas Kalincik, Prof Alessandra Lugaresi

  7. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

    Article • Annals of Neurology, October 2014, Wiley

    Dr Tim Spelman